Abstract:Aim To explore the effects and mechanism of ApoAⅠ on TNF-α expression in macrophages and plasma TNF-α levels from atherosclerotic mice.Methods Male ApoE-/-mice were fed with high cholesterol diet for 12 weeks and then randomly divided into control group,ApoAⅠ group and ApoAⅠ+AG490(a specific JAK2 inhibitor)group;each group were separately received treatment with PBS,ApoAⅠ (40 μg/g),ApoAⅠ (40μ,g/g) +AG490(4 μg/g) on the third and the first day before sacrifice,12 h before sacrifice all groups were administered with LPS via intraperitoneal injection,TNF-α levels in plasma were measured by ELISA.THP-1 macrophage-derived foam cells were randomly divided into control group,ApoAⅠ(10 mg/L) group and ApoAI(10 mg/L)+AG490(25 μmol/L) group;all groups incubated with LPS (10 μg/L).TNF-α level in supernate were measured by ELISA and TNF-α mRNA expression were examined by RT-PCR.Results Compared with the control group,ApoAⅠ can significandy decrease TNF-α levels in mice plasma,after administered with AG490 ApoAⅠ-inhibition of TNF-α secretion induced by LPS markedly weakened(P＜0.05).In vitro study demonstrated ApoAⅠ can inhibit TNF-α transcription and expression induced by LPS (P＜0.01),AG490 abrogated the anti-inflammatory effect of ApoAⅠ(P＜0.05).Conclusion ApoA Ⅰ inhibited TNF-α transcription and expression through JAK2/STAT3 signaling pathway.

Apolipoprotein A Ⅰ inhibit tumor necrosis factor α transcription and expression through JAK2/STAT3 signaling pathway